RxDoctor Payments Data

Hampton Crimm, MD

Cardiovascular Disease · Leesburg, VANPI 1548498736

Payments from drug & device makers

$1,772in general payments, 2019–2025

Across 84 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$237
  • Merck$211
  • Novartis$183
  • E.r. Squibb & Sons, L.L.C.$165
  • Johnson & Johnson$148
  • Amgen$140
  • plus $689 from 12 others

What the payments were for

  • Food & beverage$1,772100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,772 in reported general payments places this provider in the 50th percentile of 548 cardiovascular disease providers in Virginia.

See all cardiovascular disease providers in Virginia

Medicare billing

Part B allowed, 2024
$1,792,378
Medicare patients
2,519
Services billed
7,463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban298$418,831
EntrestoSacubitril/Valsartan40$59,557
XareltoRivaroxaban43$59,067
JardianceEmpagliflozin40$43,423
Repatha SureclickEvolocumab26$37,557
MultaqDronedarone Hcl27$15,349
Ranolazine ErRanolazine22$4,424
Metoprolol Succinate255$3,782
Valsartan81$2,343
Diltiazem 24hr Er (Cd)Diltiazem Hcl59$1,802
Ezetimibe69$1,741
Atorvastatin Calcium208$1,697
Eplerenone12$1,531
Rosuvastatin Calcium108$1,346
Losartan Potassium87$1,141

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$237$418,831298 claims
NovartisEntresto$183$59,55740 claims
Johnson & JohnsonXarelto$148$59,06743 claims
Boehringer IngelheimJardiance$44$43,42340 claims
Sanofi-aventis U.S. LLCMultaq$52$15,34927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 548 cardiovascular disease providers in Virginia.

Other cardiovascular disease in Leesburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →